Response to the Comment on "Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer"

Affiliations

Comment

Thilo Hackert et al. Ann Surg. 2020 Apr.

. 2020 Apr;271(4):e109-e110.

doi: 10.1097/SLA.0000000000003651.

¹ Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany.

No abstract available

Comment on

Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer.
Klaiber U, Schnaidt ES, Hinz U, Gaida MM, Heger U, Hank T, Strobel O, Neoptolemos JP, Mihaljevic AL, Büchler MW, Hackert T. Klaiber U, et al. Ann Surg. 2021 Jan 1;273(1):154-162. doi: 10.1097/SLA.0000000000003270. Ann Surg. 2021. PMID: 30921051
Comment on Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer.
Ren W, Ashley SW. Ren W, et al. Ann Surg. 2020 Apr;271(4):e109. doi: 10.1097/SLA.0000000000003667. Ann Surg. 2020. PMID: 31804387 No abstract available.

1. Klaiber U, Schnaidt ES, Hinz U, et al. Prognostic factors of survival after neoadjuvant treatment and resection for initially unresectable pancreatic cancer. Ann Surg 2019; [Epub ahead of print].
1. Harrington D, D’Agostino RB Sr, Gatsonis C, et al. New guidelines for statistical reporting in the journal. N Engl J Med 2019; 381:285–286.